Rising Pharmaceuticals Inc., the former unit of Aceto Corp., is the second company to free itself from a generic price fixing probe that has embroiled more than two dozen corporations and individuals. It was able to walk away with a deferred prosecution agreement due to its bankruptcy proceeding and cooperation with the Department of Justice in the US government's investigation of other generic makers.
Rising's payout of $3.1m in a criminal penalty, civil damages and restitution is a small sum. Other manufacturers may have...




